FL118, a novel camptothecin anticancer drug, is found to inhibit the growth and metastasis of colorectal cancer through the NLRP3-ASC-Caspase-1 pathway by mediating the pyroptosis of SW480 and HT29 cells. Here, CASP1 is linked to colorectal cancer.